Keros Therapeutics Inc. PS Ratio 2020–2026

PE Ratio PS Ratio Price to Book Price to FCF Net Worth

Current and historical P/S ratio for Keros Therapeutics Inc. (KROS): market cap divided by trailing twelve-month revenue. As of March 31, 2026 it is 0.89.

From: 03/31/2020To: 03/31/2026

Stock Price

TTM Revenue

PS Ratio

Keros Therapeutics Inc. PS Ratio — FAQ

Keros Therapeutics Inc. (KROS) ps ratio over the last 7 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see KROS's ps ratio history?

The chart and table above show Keros Therapeutics Inc.'s ps ratio by year and by quarter, including the growth rate.